The plastic surgeon's guide to drugs affecting hemostasis.
The plastic surgeon is encountering an unprecedented population of aging individuals who both desire cosmetic or reconstructive surgery and may require the use of medications that alter hemostasis. The increasing use of anticoagulants and platelet inhibitors in particular can create challenges for the plastic surgeon. The purpose of this review is to familiarize the surgeon with the medications that can affect hemostasis and to suggest strategies for their use in the perioperative period. Specific case examples are presented.
Muskett
Alan
A
Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Mississippi, Jackson, MS 39216-4505, USA. TKRFXRS@aol.com
Barber
W Henry
WH
Lineaweaver
William C
WC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008487:Medical History Taking; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D019651:Plastic Surgery Procedures / Q000009:adverse effects*; D018570:Risk Assessment; D013518:Surgery, Plastic; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin